BTAIVSINVA• 6 Months (Normalized)
BTAI vs INVA (BioXcel Therapeutics Inc. vs Innoviva Inc.)
Showing Closing Date Range from Mar, 15 to Sep, 11, 2026.
Normalized cumulative comparison anchored at 0.00% baseline to illustrate pure alpha, return divergence, and market momentum.
BTAI Performance $0.05
-96.69%
BioXcel Therapeutics Inc.
Normalized Baseline0.00%
INVA Performance $20.66
-6.73%
Innoviva Inc.
Normalized Baseline0.00%
Alpha Spread Margin INVA LEADS
-89.96%
INVA outperforming by 89.96%
BTAIINVA
Spread Trajectory6 Months (Normalized)
Cumulative Performance Trajectory
Interactive divergence comparison normalized at 0.00% on start date.
BTAI INVA
Comparative Historical Ledger
Daily closing prices, normalized percentages, and relative spread divergence.
Historical Quotes & Breakdown(125 dates)
| Date | BTAI Price | BTAI Gain (%) | INVA Price | INVA Gain (%) | Spread |
|---|---|---|---|---|---|
| Sep 11, 2026 | $0.05 | -96.69% | $20.66 | -6.73% | -89.96% |
| Sep 10, 2026 | $0.05 | -96.75% | $20.62 | -6.91% | -89.84% |
| Sep 09, 2026 | $0.05 | -96.95% | $21.13 | -4.60% | -92.35% |
| Sep 08, 2026 | $0.04 | -97.21% | $21.34 | -3.66% | -93.55% |
| Sep 04, 2026 | $0.07 | -95.20% | $21.33 | -3.70% | -91.50% |
| Sep 03, 2026 | $0.12 | -92.34% | $21.35 | -3.61% | -88.73% |
| Sep 02, 2026 | $0.11 | -93.05% | $21.35 | -3.61% | -89.44% |
| Sep 01, 2026 | $0.14 | -91.10% | $21.08 | -4.83% | -86.27% |
| Aug 31, 2026 | $0.16 | -89.42% | $20.77 | -6.23% | -83.19% |
| Aug 28, 2026 | $0.18 | -88.25% | $20.97 | -5.33% | -82.92% |
| Aug 27, 2026 | $0.72 | -53.31% | $20.96 | -5.37% | -47.94% |
| Aug 26, 2026 | $0.78 | -49.35% | $21.24 | -4.11% | -45.24% |
| Aug 25, 2026 | $0.74 | -51.82% | $21.17 | -4.42% | -47.40% |
| Aug 24, 2026 | $0.76 | -50.58% | $21.03 | -5.06% | -45.52% |
| Aug 21, 2026 | $0.80 | -47.79% | $21.07 | -4.88% | -42.91% |
Page 1 of 9